Word

SEER HOME

Status

Pending

Status Code

681

Status Date

Wednesday, September 4, 2024

Serial Number

79340655

Mark Type

4

Filing Date

Friday, March 11, 2022

Published for Opposition

Tuesday, October 8, 2024

Trademark Owner History

Seer Medical Pty Ltd

Classifications

9 Downloadable computer programs for medical purposes for diagnosis, monitoring, management and treatment of neurological conditions; downloadable computer programs for health purposes for diagnosis, monitoring, management and treatment of neurological conditions; downloadable computer application software for use in the provision of and access to medical treatment for neurological conditions; downloadable computer application software for the provision of medical and health information for use in body monitoring, namely, the management of epilepsy, heart and sleep disorders; downloadable computer application software for the recording, collection, organisation, management and transmission of medical and health information for diagnostic body monitoring relating to neurological and cardiac conditions and sleep disorders; downloadable software for use with medical devices for diagnosis, monitoring, management and treatment of neurological conditions; downloadable software for use with medical diagnostic devices for diagnosis, monitoring, management and treatment of neurological conditions; downloadable software for use with health monitoring devices for diagnosis, monitoring, management and treatment of neurological conditions; downloadable software for use in the treatment of epilepsy for monitoring and diagnosing neurological diseases; downloadable software for use in the management of epilepsy for monitoring and diagnosing neurological diseases; downloadable electronic publications in the nature of scientific and medical research journal articles in the field of medical treatment for epilepsy, cardiac, and sleep disorders and for providing information to patients and doctors in relation to epilepsy and other neurological and cardiac conditions and the diagnosis, monitoring, management and treatment thereof; downloadable computer database programs relating to diagnostic medical and health information for body monitoring for the management of epilepsy, heart and sleep disorders; none of the foregoing in relation to reagents, software or hardware for the analysis of proteins, proteomes, or biological data, and goods and services in the fields of biomolecules, metabolomics, lipidomics, genomics, epigenomics, proteomics, transcriptomics, and secretomics

44 Advisory services relating to medical problems; advisory services relating to medical services; health care consultancy services, namely, consulting services in the field of medical care; medical advisory services; medical analysis services relating to the treatment of patients; medical assistance; medical care services; medical counselling; medical testing and medical analysis services, all for diagnostic purposes; medical information retrieval services, namely medical information provided to medical professionals and patients from remote locations via the Internet and global computer networks through the use of archived medical images and a data storage and retrieval system; medical services; all of the foregoing in relation to the diagnosis, monitoring, management and treatment of epilepsy, neurological conditions, cardiac conditions, and sleep disorders; none of the foregoing in relation to reagents, software or hardware for the analysis of proteins, proteomes, or biological data, and goods and services in the fields of biomolecules, metabolomics, lipidomics, genomics, epigenomics, proteomics, transcriptomics, and secretomics

42 Software as a service (SAAS) services featuring software for medical purposes for diagnosis, monitoring, management and treatment of neurological conditions; software as a service (SAAS) services featuring software for health purposes for diagnosis, monitoring, management and treatment of neurological conditions; software as a service (SAAS) services featuring software for use in the medical treatment of epilepsy for monitoring and diagnosing neurological diseases, cardiac conditions, and sleep disorders; software as a service (SAAS) services featuring software, namely, providing online non-downloadable computer database programs for enabling the provision of diagnostic medical and health information for use in body monitoring including the management of epilepsy, heart and sleep disorders; software as a service (SAAS) services featuring software for the recording, collection, organisation, management and transmission of medical and health information for diagnostic body monitoring for the management of epilepsy, cardiac and sleep disorders; software as a service (SAAS) services featuring software for use with medical devices for diagnosis, monitoring, management and treatment of neurological conditions; software as a service (SAAS) services featuring software for use with medical diagnostic devices for diagnosis, monitoring, management and treatment of neurological conditions; software as a service (SAAS) services featuring software for use with health monitoring devices for diagnosis, monitoring, management and treatment of neurological conditions; software as a service (SAAS) services featuring software for use in the treatment of epilepsy for monitoring and diagnosing neurological diseases; software as a service (SAAS) services featuring software for use in the management of epilepsy for monitoring and diagnosing neurological diseases; none of the foregoing in relation to reagents, software or hardware for the analysis of proteins, proteomes, or biological data, and goods and services in the fields of biomolecules, metabolomics, lipidomics, genomics, epigenomics, proteomics, transcriptomics, and secretomics

Trademark Events

May 24, 2022

Application Filing Receipt Mailed

May 19, 2022

Sn Assigned For Sect 66a Appl From Ib

May 20, 2022

New Application Office Supplied Data Entered

Jul 13, 2022

Assigned To Examiner

Jul 14, 2022

Non-Final Action Written

Jul 15, 2022

Non-Final Action (Ib Refusal) Prepared For Review

Aug 3, 2022

Refusal Processed By Mpu

Aug 3, 2022

Non-Final Action Mailed - Refusal Sent To Ib

Aug 23, 2022

Refusal Processed By Ib

Feb 3, 2023

Teas Response To Office Action Received

Feb 3, 2023

Correspondence Received In Law Office

Feb 4, 2023

Teas/Email Correspondence Entered

Mar 13, 2023

Final Refusal Written

Mar 13, 2023

Final Refusal E-Mailed

Mar 13, 2023

Notification Of Final Refusal Emailed

May 4, 2023

Teas Change Of Owner Address Received

May 4, 2023

Teas Revoke/App/Change Addr Of Atty/Dom Rep Received

May 4, 2023

Attorney/Dom.Rep.Revoked And/Or Appointed

May 4, 2023

Teas Change Of Correspondence Received

May 4, 2023

Applicant/Correspondence Changes (Non-Responsive) Entered

Sep 13, 2023

Exparte Appeal Received At Ttab

Sep 13, 2023

Ex Parte Appeal-Instituted

Oct 25, 2023

Notification Of Possible Opposition Sent To Ib

Oct 25, 2023

Notification Of Possible Opposition Created, To Be Sent To Ib

Nov 12, 2023

Notification Of Possible Opposition - Processed By Ib

Aug 26, 2024

Teas Voluntary Amendment Received

Aug 30, 2024

Assigned To Examiner

Sep 3, 2024

Preliminary/Voluntary Amendment - Entered

Sep 3, 2024

Approved For Pub - Principal Register

Sep 3, 2024

Exparte Appeal Terminated

Aug 20, 2024

Jurisdiction Restored To Examining Attorney